Evidence map›Paper›PMID 37274884›Full record

ArticleArchives of Razi Institute2022

Angiotensin-Converting Enzyme 2 (ACE2) Gene Polymorphism in Patients with Type 2 Diabetes (

N Shamki Fayyad, H Risan Al-Rikabi

Open access · greenAbstract read
In one paragraph

Article in Archives of Razi Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

N Shamki FayyadBiology Department. College of Education for Pure Science, University of Thi-Qar University, Thi-Qar, Iraq.
H Risan Al-RikabiBiology Department. College of Education for Pure Science, University of Thi-Qar University, Thi-Qar, Iraq.
Thi Qar University · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increased levels of blood glucose associated with genetic and/or environmental risk factors have been known as Type 2 diabetes mellitus (T2D). T2D is categorized as a dangerous clinical syndrome for global public health. It has been well-documented that several candidate genes are functionally associated with T2D. One of the candidate genes linked to T2D is named Angiotensin-converting enzyme 2 (ACE2). Therefore, this study aimed to evaluate the relationship between ACE2 gene polymorphism and the development of T2D in Iraq. This study includes 150 participants (100) T2D patients and 50 healthy participants as a control group. Through the analysis of the recorded data, 78% were nonsmokers, while the rest were smokers. The current study found 61% of T2D patients suffer from hypertension (

Indexed as

Angiotensin-Converting Enzyme 2Diabetes Mellitus, Type 2GenotypeHumansIraqPolymorphism, GeneticACE2 protein, humanAngiotensin-Converting Enzyme 2ACE2PCRThi Qar populationType 2 diabetes mellitus

Identifiers

PMID37274884
PMCPMC10237552
OpenAlexW4379507862

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.